Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 80, Issue 2, 2012, Pages 379-386

  Xiang, Qingyu ^a   Yang, Yang ^a   Zhou, Zhou ^a   Zhou, Dan ^a   Jin, Yun ^a   Zhang, Zhirong ^a   Huang, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Cytotoxicity; HPMA copolymer; Hsp47 CBP2 binding peptide; SCC9 cells; Targeted delivery

Indexed keywords

COPOLYMER; FLUOROURACIL; N (2 HYDROXYPROPYL)METHACRYLAMIDE; PEPTIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL STRUCTURE; CELL SURFACE; CONFERENCE PAPER; CYTOTOXICITY; DRUG EFFICACY; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; SQUAMOUS CELL CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HSP47 HEAT-SHOCK PROTEINS; HUMANS; METHACRYLATES;

EID: 84856619301     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.10.020     Document Type: Conference Paper

References (51)

1. D.B. Longley, D.P. Harkin, and P.G. Johnston 5-Fluorouracil: mechanisms of action and clinical strategies Nat. Rev. Cancer 3 2003 330 338 (Pubitemid 37328853)
2. R.W. Brockman, and E.P. Anderson Biochemistry of cancer (metabolic aspects) Annu. Rev. Biochem. 32 1963 463 512
3. M. Nichifor, E.H. Schach, and L.W. Seyrnour Polymeric prodrugs of 5-fluorouracil J. Control. Release 48 1997 165 178 (Pubitemid 27401975)
4. T. Ouchi, Y. Hagihara, K. Takahashi, Y. Takano, and I. Igarashi Synthesis and antitumor activity of poly(ethylene glycol)s linked to 5-fluorouracil via a urethane or urea bond Drug Des. Discov. 9 1992 93 105
5. J.L. Grem 5-Fluoropyrimidines B.A. Chabner, D.L. Longo, Cancer Chemotherapy and Biotherapy Principles and Practice second ed. 1996 Lippincott-Raven Philadelphia, PA 149 211
6. G.C. Daher, B.E. Harris, and R.B. Diasio Metabolism of pyrimidine analogues and their nucleosides Pharmacol. Ther. 48 1990 189 222
7. R. Duncan Drug-polymer conjugates: potential for improved chemotherapy Anticancer Drugs 3 1992 175 210
8. H. Maeda, L.W. Seymour, and Y. Miyamoto Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo Bioconjug. Chem. 3 1992 351 362
9. R. Duncan The dawning era of polymer therapeutics Nat. Rev. Drug Discov. 2 2003 347 360 (Pubitemid 37361705)
10. J. Kopeček, and P. Kopečková HPMA copolymers: origins, early developments, present, and future Adv. Drug Deliv. Rev. 62 2010 122 149
11. B. Ríhová, M. Jelínková, J. Strohalm, V. Subr, D. Plocová, O. Hovorka, M. Novák, D. Plundrová, Y. Germano, and K. Ulbrich Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab′)(2)-targeted conjugates and combined therapy with immunomodulators J. Control. Release 64 2000 241 261 (Pubitemid 30035323)
12. R. Haag, and F. Kratz Polymer therapeutics: concepts and applications Angew. Chem. Int. Ed. Engl. 45 2006 1198 1215 (Pubitemid 44097641)
13. M.C. Garnett Targeted drug conjugates: principles and progress Adv. Drug Deliv. Rev. 53 2001 171 216 (Pubitemid 33135563)
14. J. Kopeček, P. Kopečková, T. Minko, Z.R. Lu, and C.M. Peterson Water soluble polymers in tumor targeted delivery J. Control. Release 74 2001 147 158 (Pubitemid 32727617)
15. W.N. Van Dijk-Wolthuis, P. van de Wetering, W.L. Hinrichs, L.J. Hofmeyer, R.M. Liskamp, D.J. Crommelin, and W.E. Hennink A versatile method for the conjugation of proteins and peptides to poly[2-(dimethylamino)ethyl methacrylate] Bioconjug. Chem. 10 1999 687 692 (Pubitemid 29355248)
16. J. Kopeček Soluble biomedical polymers Polim. Med. 7 1977 191 221
17. V. Chytrý, A. Vrána, and J. Kopeček Synthesis and activity of a polymer which contains insulin covalently bound on a copolymer of N-(2-hydroxypropyl)methacrylamide and N-methacryloyldiglycyl p-nitrophenyl ester Makromol. Chem. 179 1978 329 336
18. B. Obereigner, M. Burešová, A. Vrána, and J. Kopeček Preparation of polymerizable derivatives of N-(4- aminobenzenesulfonyl)-n′-butylurea J. Polym. Sci.: Polym. Symp. 66 1979 41 52
19. J. Kopeček, P. Kopečková, T. Minko, and Z. Lu HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action Eur. J. Pharm. Biopharm. 50 2000 61 81 (Pubitemid 30326689)
20. V. Šubr, J. Kopeček, J. Pohl, M. Baudyš, and V. Kostka Cleavage of oligopeptide side-chains in N-(2-hydroxpropyl)meth-acrylamide copolymers by mixtures of lysosomal enzymes J. Control. Release 8 1988 133 140 (Pubitemid 19010920)
21. D. Putnam, and J. Kopeček Polymer Conjugates with Anticancer Activity, Biopolymers II 1995 Springer Berlin pp. 55-123
22. L.W. Seymour, R. Duncan, J. Strohalm, and J. Kopeček Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats J. Biomed. Mater. Res. 21 1987 1341 1358
23. A. Mitra, A. Nan, H. Ghandehari, E. McNeill, J. Mulholland, and B.R. Line Technetium-99m-labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution Pharm. Res. 21 2004 1153 1159 (Pubitemid 38954199)
24. L.W. Seymour, D.R. Ferry, D.J. Kerr, D. Rea, M. Whitlock, R. Poyner, C. Boivin, S. Hesslewood, C. Twelves, R. Blackie, A. Schatzlein, D. Jodrell, D. Bissett, H. Calvert, M. Lind, A. Robbins, S. Burtles, R. Duncan, and J. Cassidy Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectalcancer Int. J. Oncol. 34 2009 1629 1636
25. B. Rihova, and K. Kubackova Clinical implications of N-(2-hydroxypropyl) methacrylamide copolymers Curr. Pharm. Biotechnol. 4 2003 311 322 (Pubitemid 37220863)
26. L.W. Seymour, D.R. Ferry, D. Anderson, S. Hesslewood, P.J. Julyan, R. Payner, J. Doran, A.M. Young, S. Burtles, and D.J. Kerr Hepatic drug targeting: phase I evaluation of polymer bound doxorubicin J. Clin. Oncol. 20 2002 1668 1676 (Pubitemid 34260549)
27. V.R. Caiolfa, M. Zamai, A. Fiorino, E. Frigerio, C. Pellizzoni, R. d'Argy, A. Ghiglieri, M.G. Castelli, M. Farao, E. Pesenti, M. Gigli, F. Angelucci, and A. Suarato Polymer-bound camptothecin: initial biodistribution and antitumour activity studies J. Control. Release 65 2000 105 119 (Pubitemid 30122920)
28. T. Ouchi, K. Hagita, M. Kwashima, T. Inoi, and T. Tahiro Synthesis and antitumor activity of vinyl polymers containing 5-fluorouracils attached via carbamoyl bonds to organosilicon groups J. Control. Release 8 1988 141 150 (Pubitemid 19011667)
29. S. Ozaki, J. Ohnishi, Y. Watanabe, T. Nohda, T. Nagase, T. Akiyama, N. Uehara, and A. Hoshi Preparation of potentially antitumor-active vinyl polymers having 5-fluorouracil unit as a component Polym. J. 21 1989 955 958 (Pubitemid 20647566)
30. F. Yang, and R. Zhuo Synthesis and antitumor activity of poly(l-cysteine) bonded covalently 5-fluorouracil Polym. J. 22 1990 572 577 (Pubitemid 20733169)
31. Y. Ohya, T.Z. Huang, T. Ouchi, K. Hasegawa, J. Tamura, K. Kadowaki, T. Matumoto, S. Suzuki, and M. Suzuki Synthesis and antitumor activity of α-1,4-polygalactosamine and N-acetyl-α-1,4-polygalactosamine immobilized 5-fluorouracils through hexamethylene spacer groups via urea, urea bonds J. Control. Release 17 1991 259 266
32. Y. Ohya, K. Inosaka, and T. Ouchi Synthesis and antitumor activity of 6-O-carboxymethyl chitin fixing 5-fluorouracils through pentamethylene, monomethylene spacer groups via amide, ester bonds Chem. Pharm. Bull. 40 1992 559 561
33. D. Putnam, and J. Kopeček Enantioselective release of 5-fluorouracil from N-(2-hydroxypropyl)methacrylamide-based copolymers via lysosomal enzymes Bioconjug. Chem. 6 1995 483 492
34. F. Yuan, F. Chen, Q.Y. Xiang, X. Qin, Z.R. Zhang, and Y. Huang Synthesis and characterization of HPMA copolymer-5-FU conjugates Chinese Chem. Lett. 19 2008 137 140
35. F. Yuan, X. Qin, D. Zhou, Q.Y. Xiang, M.T. Wang, Z.R. Zhang, and Y. Huang In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates Eur. J. Pharm. Biopharm. 70 2008 770 776
36. J.J. Sauk, R.D. Coletta, K. Norris, and C. Hebert Binding motifs of CBP2 a potential cell surface target for carcinoma cells J. Cell. Biochem. 78 2000 251 263 (Pubitemid 30415902)
37. C. Hebert, R.D. Coletta, K. Norris, N. Nikitakis, M. Lopes, and J.J. Sauk Non-natural CBP2 binding peptides and peptomers modulate carcinoma cell adhesion and invasion J. Cell. Biochem. 82 2001 145 154
38. J. Strohalm, and J. Kopeček Poly[N-(2-hydroxypropyl) methacrylamide] Angew. Makromol. Chem. 70 1978 109
39. P. Rejmanova, J. Labsky, and J. Kopeček Aminolyses of monomeric and polymeric p-nitrophenyl esters of methacryloylated amino acids Makromol. Chem. 178 1977 2159 2168
40. K. Ulbrich, V. Šubr, J. Strohalm, D. Plocová, M. Jelínková, and B. Říhová Polymeric drugs based on conjugates of synthetic and natural macromolecules: I. Synthesis and physico-chemical characterization J. Control. Release 64 2000 63 79 (Pubitemid 30035308)
41. V. Omelyanenko, P. Kopečková, C. Gentry, and J. Kopeček Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate J. Control. Release 53 1998 25 37 (Pubitemid 28218687)
42. R.C. Rathi, P. Kopečková, B. Říhová, and J. Kopeček N-(2-hydroxypropyl) methacrylamide copolymers containing pendant saccharide moieties: synthesis and bioadhesive properties J. Polym. Sci. Part A: Polym. Chem. 29 1991 1895 1902
43. V. Omelyanenko, P. Kopečková, C. Gentry, J.G. Shiah, and J. Kopeček HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. Influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro J. Drug Target. 3 1996 357 373 (Pubitemid 26059826)
44. M.B. Hansen, S.E. Nielsen, and K. Berg Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill J. Immunol. Methods 119 1989 203 210 (Pubitemid 19132276)
45. T. Minko, P. Kopečeková, V. Pozharov, and J. Kopeček HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line J. Control. Release 54 1998 223 233 (Pubitemid 28342701)
46. H. Maeda, G.Y. Bharate, and J. Daruwalla Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. European J. Pharm. Biopharm. 71 2009 409 419
47. M.P. Borgman, A. Ray, R.B. Kolhatkar, E.A. Sausville, A.M. Burger, and H. Ghandehari Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy Pharm. Res. 26 2009 1407 1418
48. M.P. Borgman, O. Aras, S. Geyser-Stoops, E.A. Sausville, and H. Ghandehari Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery Mol. Pharm. 6 2009 1836 1847
49. N. Larson, A. Ray, A. Malugin, D.B. Pike, and H. Ghandehari HPMA copolymer-aminohexylgeldanamycin conjugates targeting cell surface expressed GRP78 in prostate cancer Pharm. Res. 27 2010 2683 2693
50. A. Nan, H. Ghandehari, C. Hebert, H. Siavash, N. Nikitakis, M. Reynolds, and J.J. Sauk Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck J. Drug Target. 13 2005 189 197 (Pubitemid 40668172)
51. F. Giantomassi, A.F. Gualtieri, L. Santarelli, M. Tomasetti, G. Lusvardi, G. Lucarini, M. Governa, and A. Pugnaloni Biological effects and comparative cytotoxicity of thermal transformed asbestos-containing materials in a human alveolar epithelial cell line Toxicol. in Vitro 24 2010 1521 1531